Search Results 1211-1220 of 18372 for prostate cancer
2019.20675. Prostate cancer. National Comprehensive Cancer Network. https://www.nccn.org/professionals/physician_gls/default.aspx. Accessed March 3, 2026 ...
... prostate cancer. Presenter: Minji Lee, Ph ... prostate-specific antigen kinetics to predict prostate cancer recurrence after definitive radiation therapy.
, Kidney stone, Kidney cancer, Prostate cancer, Bladder cancer, Ureteral obstruction, Benign prostatic hyperplasia, Voiding dysfunction ... tumor, Mediastinal ...
... prostate cancer that has come back, also called recurrent prostate cancer. Mayo Clinic was the first FDA-approved facility to produce choline C-11 ...
According to the American Cancer Society, there are nearly 12,000 estimated new cases of prostate cancer in Florida this year. Mayo Clinic also will offer ...
... prostate cancer. But other studies say high levels of omega-3s might prevent prostate cancer. None of these studies was definite. More research is needed ...
As chemotherapy and radiation enable patients with breast, lung or prostate cancer or melanoma to live longer, metastatic disease may arise.
Prostate cancer. Cost-effectiveness analysis. Benign prostatic hyperplasia (BPH). Nephrolithiasis. Upper tract urothelial carcinoma. Image-guided surgery ...
d neck cancer, Prostate cancer, Bladder cancer, Testicular cancer, Penile cancer, Breast cancer, Skin cancer, Bone metastasis. Show more areas of focus for ...
Immunotherapy (APC8015, Provenge) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: a Phase ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.